
Labfront is a digital biomarker company aiming to democratize research by providing an all-in-one platform for real-world data collection, participant management, and data analysis. It supports researchers across various fields, including psychology, sports science, sleep studies, and women's health. The platform aggregates physiological data from wearables, survey responses, and event tracking, offering a comprehensive view of research subjects. Labfront also provides advanced analytics services through its expert team, helping researchers gain insights faster. Key features include secure data storage compliant with HIPAA, GCP, and SOC standards, as well as a user-friendly interface for data visualization. The company has a tiered pricing model, offering solutions from free testing to advanced plans with customizable sampling rates and extensive device integrations.

Labfront is a digital biomarker company aiming to democratize research by providing an all-in-one platform for real-world data collection, participant management, and data analysis. It supports researchers across various fields, including psychology, sports science, sleep studies, and women's health. The platform aggregates physiological data from wearables, survey responses, and event tracking, offering a comprehensive view of research subjects. Labfront also provides advanced analytics services through its expert team, helping researchers gain insights faster. Key features include secure data storage compliant with HIPAA, GCP, and SOC standards, as well as a user-friendly interface for data visualization. The company has a tiered pricing model, offering solutions from free testing to advanced plans with customizable sampling rates and extensive device integrations.
Founded: 2021
Product: Digital-biomarker platform that aggregates wearable physiological data, EMA surveys, event/adherence tracking, visualization, and analytics
Compliance: HIPAA, ICH‑GCP, SOC (1/2/3), GDPR
Funding: Total disclosed $2,100,000 USD; last round listed as Pre-Seed on 2022-10-03
Team size: 19 employees
Chris Peng (Co‑Founder & CEO); Jordan Masys (Co‑Founder & COO)
Real-world data collection and analysis for health research (digital biomarkers).
2021
Digital biomarker / Real-world data research platform
2100000.00 USD
Crunchbase lists the most recent round as Pre-Seed; company participated in the 500 Global Accelerator (Taiwan).